Completed Heart, Stroke & Blood Bones, Joints & Muscles

Regulation of vascular smooth muscle cell apoptosis and cell senescence in atherosclerosis

In plain English

AI plain-English summary

Arteries clogged with fatty plaques are failing to repair themselves because their muscle cells are dying or going into a state of suspended animation instead of dividing to patch the damage. In healthy blood vessels, when smooth muscle cells die, neighbouring cells multiply to replace them—a process called apoptosis-induced compensatory proliferation (AICP). But in atherosclerosis, this repair mechanism stalls. The research will test whether cell senescence—a kind of cellular ageing—blocks AICP, and whether DNA damage from the cell’s nucleus or its mitochondria is the root cause. The team will also examine how damaged mitochondria trigger senescence in the first place. If the work identifies the DNA damage response or mitochondrial dysfunction as key drivers of plaque vulnerability, those pathways could become targets for new drugs. The goal is not to reverse advanced atherosclerosis overnight, but to stabilise dangerous plaques so they are less likely to rupture and cause heart attacks or strokes. This is fundamental science: it asks how cells decide to repair or retire, a question with implications far beyond heart disease. Similar mechanistic work on cell division and death has previously opened the door to cancer therapies and drugs that slow ageing.

View original technical description
Vascular smooth muscle cell (VSMC) death by apoptosis and senescence are seen in advanced human atherosclerotic plaques. Recent work has shown that DNA damage and mitochondrial dysfunction are also present in plaques, induce VSMC death and senescence and increase monocyte pro-inflammatory cytokine release, promoting both atherosclerosis and features of plaque vulnerability. In remodelling of normal vessels VSMC apoptosis is followed by apoptosis-induced compensatory proliferation (AICP) that repairs the vessel wall, but this is not seen in atherosclerosis. This programme will determine the mechanisms underlying VSMC AICP, whether senescence prevents AICP in atherosclerosis, the consequences of nuclear and mitochondrial oxidative DNA damage, and how mitochondrial dysfunction induces senescence. The programme will identify whether the DNA damage response (DDR) or mitochondrial dysfunction are therapeutic targets in atherosclerosis.

View the original record at the funder ↗

Researchers

Martin Bennett (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Causes, consequences and therapeutic potential of cell senescence in atherosclerosis (renewal)
Smooth muscle cell regulation of vascular ageing
Mechanisms of vascular smooth muscle cell ageing and calcification – towards novel therapeutic interventions.
Do IL-1R2 and inflammatory caspases regulate IL-1 in senescence and atherosclerosis?
How can we target senescent cell-driven vascular inflammation whilst sparing host defence?

Original classification

Programme Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.